NO860332L - Fremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydro-tieno(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydro-tieno(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.

Info

Publication number
NO860332L
NO860332L NO860332A NO860332A NO860332L NO 860332 L NO860332 L NO 860332L NO 860332 A NO860332 A NO 860332A NO 860332 A NO860332 A NO 860332A NO 860332 L NO860332 L NO 860332L
Authority
NO
Norway
Prior art keywords
hexsahydro
tieno
pyridyl
oxo
phenyl
Prior art date
Application number
NO860332A
Other languages
English (en)
Other versions
NO162965C (no
NO162965B (no
Inventor
Alain Badorc
Daniel Frehel
Jean-Pierre Maffrand
Eric Vallee
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO860332L publication Critical patent/NO860332L/no
Publication of NO162965B publication Critical patent/NO162965B/no
Publication of NO162965C publication Critical patent/NO162965C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO860332A 1985-01-31 1986-01-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydrotieno-(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater. NO162965C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8501908A FR2576901B1 (fr) 1985-01-31 1985-01-31 Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique

Publications (3)

Publication Number Publication Date
NO860332L true NO860332L (no) 1986-08-01
NO162965B NO162965B (no) 1989-12-04
NO162965C NO162965C (no) 1990-03-14

Family

ID=9316132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860332A NO162965C (no) 1985-01-31 1986-01-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydrotieno-(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.

Country Status (24)

Country Link
US (1) US4740510A (no)
EP (1) EP0192535A1 (no)
JP (1) JPS61246186A (no)
AU (1) AU581487B2 (no)
CA (1) CA1265517A (no)
CS (1) CS253741B2 (no)
DD (1) DD242229A5 (no)
DK (1) DK157553C (no)
ES (1) ES8703881A1 (no)
FI (1) FI860473A (no)
FR (1) FR2576901B1 (no)
GR (1) GR860287B (no)
HU (1) HU193625B (no)
IL (1) IL77598A (no)
MA (1) MA20619A1 (no)
NO (1) NO162965C (no)
NZ (1) NZ214982A (no)
OA (1) OA08196A (no)
PL (1) PL145159B1 (no)
PT (1) PT81946B (no)
SU (1) SU1389679A3 (no)
TN (1) TNSN86012A1 (no)
YU (1) YU11986A (no)
ZA (1) ZA86407B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
DE69526443T2 (de) * 1994-10-07 2002-12-12 Ube Industries, Ltd. 2-silyloxy-tetrahydrothienopyridin, sein salz und verfahren zu seiner herstellung
NZ334389A (en) * 1996-08-28 2001-05-25 Ube Industries Cyclic amine derivatives
NZ506574A (en) 1998-02-27 2003-06-30 Sankyo Co Cyclic amino derivative having a sulphinyl, sulphonyl or disulphanyl group useful in the treatment of thrombosis or embolism
PT1728794E (pt) 2000-07-06 2008-07-15 Ube Industries Sal de adição maleato de derivados de hidropiridina
HUP0400644A3 (en) * 2000-12-25 2009-06-29 Ube Industries Pharmaceutical compositions containing aspirin
GB0125708D0 (en) * 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
CZ302135B6 (cs) * 2007-07-09 2010-11-10 Zentiva, A. S. Zpusob výroby 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4, 5, 6, 7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu (prasugrelu)
WO2009062044A2 (en) * 2007-11-09 2009-05-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel, and its salts and polymorphs
WO2009066326A2 (en) * 2007-11-19 2009-05-28 Msn Laboratories Limited Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts
CN101289454B (zh) * 2008-06-10 2011-02-16 上海医药工业研究院 2-氧-2,4,5,6,7,7α-六氢噻吩并[3,2-c]吡啶的制备方法
DE102008046630A1 (de) * 2008-09-10 2010-03-11 Emitec Gesellschaft Für Emissionstechnologie Mbh Modulares Tanksystem für ein flüssiges Reduktionsmittel mit einem Sumpfelement
CN101402593A (zh) * 2008-11-11 2009-04-08 上海现代制药股份有限公司 用于制备普拉格雷的中间体及其制备方法
CN101402643B (zh) * 2008-11-11 2012-11-28 上海现代制药股份有限公司 一种适于工业生产的普拉格雷的制备方法
CN101402642B (zh) * 2008-11-11 2013-01-09 上海现代制药股份有限公司 一种新型环保制备普拉格雷的方法
CZ2008748A3 (cs) 2008-11-26 2010-06-02 Zentiva, A. S Zpusob výroby vysoce cistého 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c] pyridin-2-yl acetátu, prasugrelu
US20120202066A1 (en) * 2009-10-07 2012-08-09 Manne Satyanarayana Reddy Processes For Preparing Prasugrel And Pharmaceutically Acceptable Salts Thereof
HU229031B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel and its intermediate
HU229035B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel
CN102863457B (zh) * 2010-02-02 2013-10-09 江苏威凯尔医药科技有限公司 光学活性2-羟基四氢噻吩并吡啶衍生物及其制备方法与在制药中的用途
EP2545059A1 (en) 2010-03-09 2013-01-16 Synthon BV A process for making prasugrel
CN102212069A (zh) * 2010-04-06 2011-10-12 刘桂坤 环烷衍生物及其制备方法和在心脑血管病药物上的应用
CN101845052B (zh) * 2010-06-11 2012-01-11 天津药物研究院 一类含氮杂环的噻吩并吡啶酮衍生物、其制备方法和用途
EP2613783B1 (en) * 2010-08-26 2019-06-12 IPCA Laboratories Limited Methods for the treatment or prophylaxis of thrombosis or embolism
CN101948479B (zh) * 2010-09-29 2013-01-30 横店集团家园化工有限公司 普拉格雷中间体及其制备方法
CN101985451B (zh) * 2010-11-02 2012-04-25 北京赛科药业有限责任公司 普拉格雷中间体的制备方法
CN102002056B (zh) * 2010-11-02 2012-04-25 北京赛科药业有限责任公司 一种普拉格雷中间体的制备方法
CN102276623A (zh) * 2011-06-13 2011-12-14 安徽省虹升生物科技有限公司 一种利用有机硅保护剂进行制备普拉格雷的新方法
CA2839608C (en) * 2011-06-27 2020-07-14 Ipca Laboratories Limited (7as,2's)-2-oxoclopidogrel as anti-thrombotic compounds
CN104341433B (zh) * 2013-08-02 2017-12-15 鲁南制药集团股份有限公司 一种普拉格雷中间体的制备方法
CN104447867B (zh) * 2013-09-17 2017-12-26 江苏天士力帝益药业有限公司 一种噻吩并哌啶衍生物、制备方法及其应用
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
CN108570060A (zh) * 2018-05-13 2018-09-25 日照市普达医药科技有限公司 一种4,5,6,7-四氢噻吩并[3,2-c]吡啶类衍生物对血栓的治疗作用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495157A1 (fr) * 1980-11-28 1982-06-04 Sanofi Sa Procede nouveau de preparation des tetrahydro-5, 6, 7, 7a 4h-thieno (3, 2-c) pyridinones-2
FR2495156A1 (fr) * 1980-11-28 1982-06-04 Sanofi Sa Derives de la thieno-pyridinone, leur procede de preparation et leur application therapeutique
FR2528848A1 (fr) * 1982-06-16 1983-12-23 Sanofi Sa Nouveau derive de thieno-pyridone, son procede de preparation et son application therapeutique
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
DE3302125A1 (de) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung

Also Published As

Publication number Publication date
GR860287B (en) 1986-06-02
AU581487B2 (en) 1989-02-23
FI860473A (fi) 1986-08-01
DK47186D0 (da) 1986-01-30
FR2576901B1 (fr) 1987-03-20
ES8703881A1 (es) 1987-03-01
HU193625B (en) 1987-11-30
PL257691A1 (en) 1986-11-04
PT81946B (pt) 1987-12-30
IL77598A (en) 1988-12-30
YU11986A (en) 1987-08-31
DK157553B (da) 1990-01-22
EP0192535A1 (fr) 1986-08-27
ES550448A0 (es) 1987-03-01
AU5242486A (en) 1986-08-07
CA1265517A (fr) 1990-02-06
OA08196A (fr) 1987-10-30
NO162965C (no) 1990-03-14
SU1389679A3 (ru) 1988-04-15
HUT40440A (en) 1986-12-28
CS253741B2 (en) 1987-12-17
PT81946A (fr) 1986-02-01
TNSN86012A1 (fr) 1990-01-01
NO162965B (no) 1989-12-04
US4740510A (en) 1988-04-26
FI860473A0 (fi) 1986-01-31
MA20619A1 (fr) 1986-10-01
FR2576901A1 (fr) 1986-08-08
ZA86407B (en) 1986-09-24
DD242229A5 (de) 1987-01-21
DK157553C (da) 1990-06-11
DK47186A (da) 1986-08-01
JPS61246186A (ja) 1986-11-01
NZ214982A (en) 1988-04-29
PL145159B1 (en) 1988-08-31

Similar Documents

Publication Publication Date Title
NO860332L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydro-tieno(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO863061D0 (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO863671D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
NO883122D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO870049D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
FI871087A (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
NO863373L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
NO860091L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater.
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO171499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater
NO168825C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater
NO166322C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater.
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.